Recently Enacted Law Offers New Exclusivity Incentives for Drugs Containing "Old" Antibiotics

Recently Enacted Law Offers New Exclusivity Incentives for Drugs Containing "Old" Antibiotics

Client News
On October 8, 2008, President Bush signed into law S. 3560, the QI Program Supplemental Funding Act of 2008 (Public Law Number 110-379), which, among other things, amends the Federal Food, Drug, and Cosmetic Act (FDCA) to create new exclusivity opportunities for drug products containing "old" antibiotic ingredients. S. 3560 reverses certain provisions of the Food and Drug Administration Modernization Act of 1997 (FDAMA) that exempted products containing "old" antibiotics from the Hatch-Waxman provisions regarding marketing exclusivity and the patent listing and certification process. The new law accomplishes this in different ways for different categories of "old" antibiotics. For more, see our recent Email Alert.

Notice

We appreciate your interest in WilmerHale. While we are pleased to have you contact us, please keep in mind that merely contacting WilmerHale does not create an attorney-client relationship. Such a relationship will not arise until the Firm agrees in writing to represent you in connection with a particular matter. Importantly, unless and until this has occurred, you should not provide us with any confidential information, and we have no duty to keep confidential any information that we may receive from you. Thank you for your understanding.

I Accept Cancel